1. Home
  2. NVCR vs NBTB Comparison

NVCR vs NBTB Comparison

Compare NVCR & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • NBTB
  • Stock Information
  • Founded
  • NVCR 2000
  • NBTB 1856
  • Country
  • NVCR Switzerland
  • NBTB United States
  • Employees
  • NVCR N/A
  • NBTB N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • NBTB Major Banks
  • Sector
  • NVCR Health Care
  • NBTB Finance
  • Exchange
  • NVCR Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • NVCR 2.3B
  • NBTB 2.3B
  • IPO Year
  • NVCR 2015
  • NBTB N/A
  • Fundamental
  • Price
  • NVCR $17.82
  • NBTB $42.90
  • Analyst Decision
  • NVCR Strong Buy
  • NBTB Hold
  • Analyst Count
  • NVCR 4
  • NBTB 3
  • Target Price
  • NVCR $37.50
  • NBTB $54.67
  • AVG Volume (30 Days)
  • NVCR 795.3K
  • NBTB 264.6K
  • Earning Date
  • NVCR 05-01-2025
  • NBTB 04-21-2025
  • Dividend Yield
  • NVCR N/A
  • NBTB 3.17%
  • EPS Growth
  • NVCR N/A
  • NBTB 12.07
  • EPS
  • NVCR N/A
  • NBTB 2.97
  • Revenue
  • NVCR $605,220,000.00
  • NBTB $557,339,000.00
  • Revenue This Year
  • NVCR $3.41
  • NBTB $26.01
  • Revenue Next Year
  • NVCR $9.24
  • NBTB $12.39
  • P/E Ratio
  • NVCR N/A
  • NBTB $14.45
  • Revenue Growth
  • NVCR 18.82
  • NBTB 13.66
  • 52 Week Low
  • NVCR $11.70
  • NBTB $32.93
  • 52 Week High
  • NVCR $34.13
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 33.96
  • NBTB 36.38
  • Support Level
  • NVCR $18.23
  • NBTB $42.25
  • Resistance Level
  • NVCR $19.06
  • NBTB $44.67
  • Average True Range (ATR)
  • NVCR 0.80
  • NBTB 0.89
  • MACD
  • NVCR 0.02
  • NBTB 0.11
  • Stochastic Oscillator
  • NVCR 5.57
  • NBTB 27.16

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: